Business Details
Trusted Capital Advisors for Healthcare & Life Science Innovators
New Harbor Venture Partners (NHVP) is a specialized placement agent dedicated to raising capital for venture-backed and private-equity backed healthcare and life science companies. Our team of four senior executives brings decades of global experience in investment and fund-raising, building on a legacy established through Rockport Venture Partners' 16-year success in connecting European venture communities with US life sciences innovators. We focus on creating strategic partnerships between industry-focused investors and forward-thinking entrepreneurs, leveraging our deep sector expertise and international network to deliver tailored capital solutions.Our track record includes high-impact transactions across infusion technology, AR navigation systems, eyecare diagnostics, and precision irrigation management, demonstrating our commitment to advancing transformative healthcare innovations. With offices in the United States and Switzerland, we maintain a global perspective while providing personalized advisory services that prioritize long-term client relationships and sustainable growth outcomes.
Services
Capital Raising
Venture Capital Advisory
Private Equity Advisory
Healthcare Sector Focus
Life Sciences Sector Focus
Highlights and features
- We offer 16+ years of legacy experience from Rockport Venture Partners' successful European-US market connections
- Our team includes four senior executives with global fund-raising expertise across healthcare sectors
- We specialize in healthcare and life sciences with proven success in infusion technology and AR navigation deals
- We maintain a global network spanning North America, Europe, and Switzerland for strategic capital access
- Our personalized approach prioritizes long-term relationships over transactional deal-making
Services
Capital Raising
We specialize in securing growth capital for healthcare and life science companies through strategic investor connections. Our proven methodology combines sector-specific expertise with global market insights to identify optimal funding partners. With a track record of successful transactions exceeding $240 million, we deliver tailored capital solutions that align with each company's growth trajectory and innovation goals.
Venture Capital Advisory
Our advisory services guide emerging healthcare companies through venture capital acquisition processes. We leverage deep industry relationships to connect innovators with investors specializing in medical technology and biopharmaceutical advancements. Our approach emphasizes long-term partnership development rather than transactional deal-making, ensuring sustained growth support for portfolio companies.
Private Equity Advisory
We facilitate private equity investments in established healthcare organizations seeking expansion capital. Our expertise spans infusion technology, diagnostic systems, and medical device sectors. Through targeted investor outreach and comprehensive market analysis, we create value-driven partnerships that support operational scaling and technological innovation in healthcare delivery.
People
Mark Bosland
Founder & President
Founder of New Harbor Venture Partners with 16-year legacy from Rockport Venture Partners. Specializes in connecting European and US healthcare innovators with strategic investors through personalized capital solutions.
Beat Merz
Managing Director Europe
PhD-holding executive with expertise in European healthcare markets. Leads NHVP's European operations, leveraging scientific background to evaluate investment opportunities in life science innovations and medical technologies.
Jake Hindelong
Managing Director United States
Seasoned capital markets professional managing US operations. Focuses on connecting domestic healthcare innovators with global investment partners through strategic relationship-building and sector-specific market insights.
Questions
What healthcare sectors do you specialize in?
We focus on life sciences, medical technology, biopharmaceuticals, and digital health innovations with particular expertise in infusion systems, diagnostic tools, and precision medicine applications.
How do you differ from generalist investment banks?
Our exclusive healthcare focus provides deeper sector knowledge and more targeted investor connections compared to generalist firms, ensuring better alignment between companies and specialized capital partners.
What transaction sizes do you handle?
We work with growth-stage companies seeking $50M+ capital raises, with recent transactions ranging up to $240M upfront payments plus milestone agreements in medical device acquisitions.
Do you work with international companies?
Yes, our global network spans North America, Europe, and Switzerland, enabling cross-border capital raising and strategic partnership opportunities for healthcare innovators worldwide.
